Markham, ON – Recipients of the third annual CUA Astellas Research Grant Program have been announced by the Canadian Urological Association and Astellas Pharma Canada.
In 2012, Astellas pledged $750,000 over a period of five years to the program, which supports Canadian peer-reviewed urology research.
“The Canadian researchers awarded with CUA-Astellas research grants have exceptional ideas that have the potential to make significant contributions to the lives of patients and the urological medical community,” said Dr. Ricardo A. Rendon, chair of the Scientific Council of the Canadian Urological Association Scholarship Foundation (CUASF). “Over the past two years, the substantial contributions of past recipients are already having a remarkable impact on improving understanding and treatment of functional urological conditions. We are eager to see where the visionary research of this year’s recipients and future recipients lead.”
This year, 11 research proposals for the 2014 CUA-Astellas Research Grant Program were reviewed by an independent committee comprised of nine medical researchers and one external reviewer, and chaired by Dr. Ricardo A. Rendon.
The 2014 recipients are:
- Dr. Luis Braga, McMaster University. Project: Continuous antibiotic prophylaxis versus placebo in infants diagnosed with primary megaureter: A prospective randomized controlled trial.
- Dr. Dirk Lange, University of British Columbia. Project: Identifying differences in intestinal microbial composition between patients with recurrent kidney stone disease and on stone-forming control.
- Dr. Andrea Lantz, Dalhousie University. Projecct: Ureteral stent-related pain and Mirabegron (SPAM) trial.